ArticlePLoS neglected tropical diseases2026
Implantation mycoses: A nationwide survey on diagnostic and treatment modalities in Nepal.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Implantation mycoses (IM) are a group of fungal diseases which occur after a transcutaneous trauma. The World Health Organization has listed some of the IM, namely sporotrichosis, chromoblastomycosis and eumycetoma as one of the Skin Neglected Tropical Diseases targeted for control by 2030. There are no robust data on IM from Nepal since these diseases are not a part of routine disease surveillance. In this study, an online and in-person survey was conducted using a standard set of questionnaires among the registered dermatologists of Nepal. For this survey sporotrichosis, chromoblastomycosis and mycetoma were included. A total of 56 dermatologists responded to this survey. The result showed that sporotrichosis was the most diagnosed IM (46/56, 82.15%) whereas mycetoma was the least common (21/56, 37.5%). This study further explored the availability of the various diagnostics and treatment modalities among these IM in Nepal. It also showed a lack of uniformity in treatment modalities and in the availability of diagnostics as well as treatment options across the country. It showed that the diagnostics and treatment options were more in the capital as compared to rest of the country.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.